Younok Dumortier Shin

Nessuna posizione attualmente

Consumer Services

Health Technology

Commercial Services

Profilo

Younok Dumortier Shin served as Vice President & Managing Director at Dermelix Biotherapeutics, LLC.
She was also the Chief Technology Officer at Avalo Therapeutics, Inc. from 2020 to 2022.
She holds a graduate and doctorate degree from McGill University, an MBA from Babson College, and an undergraduate degree from the University of British Columbia.

Precedenti posizioni note di Younok Dumortier Shin

Società	Posizione	Fine
AVALO THERAPEUTICS, INC.	Direttore Tecnico/Scientifico/R&S	01/02/2022
Dermelix Biotherapeutics, Llc Dermelix Biotherapeutics, Llc Miscellaneous Commercial ServicesCommercial Services Dermelix Biotherapeutics, LLC is a non-clinical stage biopharmaceutical company that specializes in developing treatments for patients with rare genetic skin diseases. Dermelix Biotherapeutics is based in Albany, NY. The private company's focus is on delivering effective therapies to those who suffer from these conditions.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Younok Dumortier Shin

Formazione di Younok Dumortier Shin

McGill University	Doctorate Degree
Babson College	Masters Business Admin
University of British Columbia	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Younok Dumortier Shin

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
AVALO THERAPEUTICS, INC.	Health Technology

Aziende private	1
Dermelix Biotherapeutics, Llc Dermelix Biotherapeutics, Llc Miscellaneous Commercial ServicesCommercial Services Dermelix Biotherapeutics, LLC is a non-clinical stage biopharmaceutical company that specializes in developing treatments for patients with rare genetic skin diseases. Dermelix Biotherapeutics is based in Albany, NY. The private company's focus is on delivering effective therapies to those who suffer from these conditions.	Commercial Services